Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services. As of June 30, 2021, more than 64,700 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company in the world.
Leveraging in the Group’s proprietary gene synthesis and other technology and know-hows, the Group has established four major platforms including
(i) a leading contracted research organization (“CRO”) platform to provide one-stop solutions to global research communities;
(ii) a contract development and manufacturing organization (“CDMO”) platform;
(iii) an industrial synthetic products platform; and
(iv) an integrated global cell therapy platform.